Prep for USMLEPrep for USMLE Forum
   Forum    Step 1  Step 2 CK Step 2 CS Step 3  Match  IMGs Resources Search






Previous Topic | Next Topic  Newer drugs tested on exam 




 
Kaplan Qbank USMLE



Author2 Posts
  #1

HI GUYS
I WAS SURFING ALONG N FOUND THESE NEWER DRUGS THAT R BEING TESTED IN VARIOUS EXAMS CHK THEM OUT


2005

--------------------------------
Exenatide: For the adjunctive treatment of Type 2 diabetes mellitus
Mecasermin: For the treatment of growth failure due to Primary IGFD
Pramlintide: For the treatment of type I and type II diabetes
Tipranavir: For the adjunctive treatment of HIV-1 infections
Entecavir: For the treatment of chronic hepatitis B infections with evidence of active viral replication
Ibandronate: For the treatment and prevention of osteoporosis
Galsulfase: For the treatment of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Ramelteon: For the treatment of sleep-onset insomnia
Natalizumab: For the treatment of relapsing forms of multiple sclerosis
Nelarabine: For the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma


2004
--------------------------------
Bevacizumab: For the treatment of metastatic carcinoma of the colon or rectum
Cetuximab: For the treatment of EGFR-expressing, metastatic colorectal cancer
Azacitidine: For the treatment of several myelodysplastic syndrome subtypes including refractory and chronic myelomonocytic leukemias
Telithromycin: For the treatment of infections caused by bronchitis, bacterial sinusitis and Community-acquired pneumonia
Rifaximin: For the treatment of Travelers' diarrhea caused by noninvasive strains of Escherichia coli
Fosrenol, lanthanum carbonate; For the treatment of hyperphosphatemia related to kidney dysfunction
Trospium chloride: For the treatment of overactive bladder with symptoms of urge urinary incontinence
Cinacalcet: For the treatment of secondary hyperparathyroidism and hypercalcemia in parathyroid carcinoma patients
Solifenacin succinate: For the treatment of overactive bladder with symptoms of urge urinary incontinence
Eszopiclone: For the treatment of insomnia and sleep maintenance
Natalizumab: For the treatment of relapsing forms of multiple sclerosis (currently suspended in US)
clofarabine: For the treatment of acute lymphoblastic leukemia in pediatric patients
Erlotinib, OSI 774: For the treatment of advanced refractory metastatic non-small cell lung cancer
Pegaptanib: For the treatment of wet age-related macular degeneration
Duloxetine: For the treatment of major depressive disorder
Tiotropium bromide: For the treatment of bronchospasm associated with chronic obstructive pulmonary disease




2003
--------------------------------
Rosuvastatin calcium: For the treatment of primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia
Vardenafil: For the treatment of erectile dysfunction related to sexual activity in men
Alefacept: For moderate to severe chronic plaque psoriasis
Laronidase: For the treatment of Mucopolysaccharidosis I (MPS I) in subjects aged 5 to 65
Agalsidase beta: For the treatment of Fabry disease in adult patients
Pegvisomant: Injectable formulation for the treatment of acromegaly
Palonosetron: For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy
Aprepitant: For the treatment of nausea and vomiting associated with chemotherapy
Bexxar; For the treatment of patients with CD20 positive, follicular, non-Hodgkin's lymphoma following chemotherapy relapse
Atazanavir sulfate: For the treatment of HIV-1 infection in combination with other antiretroviral agents
Zemaira (alpha1-proteinase inhibitor: For the treatment of alpha1-proteinase inhibitor deficiency (Alpha-1) and emphysema
Enfuvirtide: For the treatment of HIV-1 infection in combination with other antiretroviral agents
Fosamprenavir calcium: For the treatment of HIV infection in adults in combination with other antiretroviral agents
Atazanavir sulfate: For the treatment of HIV-1 infection in combination with other antiretroviral agents
Laronidase: For the treatment of Mucopolysaccharidosis I (MPS I) in subjects aged 5 to 65
Ibandronate: For the treatment and prevention of osteoporosis
Pegvisomant: Injectable formulation for the treatment of acromegaly
Bortezomib: Injectable agent for the treatment of multiple myeloma patients who have received at least two prior therapies
Agalsidase beta: For the treatment of Fabry disease in adult patients
Tadalafil: Oral agent for the treatment for erectile dysfunction
Memantine: For the treatment of moderate to severe dementia of the Alzheimer’s type


Palonosetron: For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy
Aprepitant: For the treatment of nausea and vomiting associated with chemotherapy
Gefitinib: For the second-line treatment of non-small-cell lung cancer
Bortezomib: Injectable agent for the treatment of multiple myeloma patients who have received at least two prior therapies.
Gefitinib: For the second-line treatment of non-small-cell lung cancer


Anakin-Ra : recombinant TL-1 receptor antagonist used in Rheumatoid Arthritis

Ranolazine & Trimetazidine : Novel anti-anginals, shift myocardial respiration from aerobic to anaerobic

Napsagatran : anti-coagulant


Aprepitant : Neurokinin1 receptor antagonist used to treat Chemotherapy induced nausea & vomiting

Azacitidine : Used in treatment of Myelodysplastic syndrome

Levosemendan : Calcium channel sensitizer used in CHF

Cromakalim : Potassium channel opener having 'NO' donating properties

Argatroban : Direct thrombin inhibitor

Exemestene : Aromatase inhibitor

Dexmedetomidine : used in de-addiction

Gefitinib : Treatment of Lung Cancer

Miltefosine : Visceral leishmaniasis

Verteporfin : Photodynamic therapy

SOME HIGH YIELD DRUGS SIDE EFFECTS

Protease Inhibitors (in general)= hyperglycemia, hyperlipidemia
(lipodystrophy)
Cisapride = Torsade
Methotrexate (long-term use)= liver fibrosis, folate deficiency
anemia
Asparaginase = pancreatitis




NITROFURANTOIN----------- CHRONIC HEPATITIS AND PULMONARY FIBROSIS

AZATHIOPRINE---------------CHOLESTASIS

OCP----------------------------HEPATIC ADENOMA



------------------------------------------------------------------------- -------

didanosine--dose dependent pancreatitis, painful peripheral neuropathy, diarrhoea, hyperuricemia, optic neuritis.


Aspirin = ototoxicity and respiratory alkalosis/metabolic acidosis
(mixed)
Quinidine = diarrhea, thrombocytopenia
Acarbose = flatuence, GI distress
Methimazole = agranlocytosis, aplastic anemia
Prazosin = First-dose syncope (give the first dose in your office


Ethosuximide = GI upset
Tolcapone = Hepatotoxicity
Thioridazine = retinal deposits, Torsade
Vancomycin = "Red Man" Syndrome
Chloramphenicol= "Gray Baby" Syndrome
Cimetidine = Gynecomastia
Ketoconazole = Gynecomastia
_________________




thioglitazone, tacrine - hepato toxicity

etomidate- adrenal suppression

chloroform, ether- hyperglycemia

nicotinic acid- icthyosis

calcium agonists- constipation!!!

azathioprine, valproate, l-asparaginase, thiazides-pancreatitis

zdv- hypochromic, megaloblastic anemia

proton pump inhibitors- redistribution of fat, hyper glycemia

outdated tetracyclines, nalidixic acid- pseudo tumour cerebri






A Quick Contra-Indications list to common drugsContraindications to Use of Antimalarials

* Allergy to 4-aminoquinoline derivatives
* Retinopathy or visual field deterioration

Contraindications to Use of Anti-Tumor Necrosis Factor (Anti-TNF) Agents

* Sepsis or clinically manifest infections and/or abscesses
* Past medical history of hypersensitivity to infliximab or other murine proteins

Contraindications to Use of Azathioprine

* Known neoplastic disease

Contraindications to Use of Cyclophosphamide

* Pregnancy
* Chronic or active infection
* Liver disease
* History of neoplasia
* Renal failure is a relative contraindication that requires adjustment of dosage.

Contraindications to Use of Cyclosporin A

* Coexisting cancer (except non-melanoma skin cancer)
* Uncontrolled hypertension
* Renal dysfunction
* Uncontrolled infections
* Primary and secondary immunodeficiency

Contraindications to Use of D-penicillamine

* Kidney disease
* Blood disorders (e.g., leukopenia, thrombocytopenia)

Contraindications to Use of Leflunomide

* Serious immunodeficiency
* Dysplasias
* Uncontrolled infection (due to the theoretical possibility of immunosuppression)
* Moderate or severe renal failure (there is no experience in this group of patients)
* Liver function disorder
* Significant bone marrow disorder
* Severe hypoproteinemia

Contraindications to Use of Methotrexate

Absolute contraindications

* Pregnancy
* Alcohol abuse
* Hepatitis B or C
* Cirrhosis of any origin

Relative contraindications

* Renal failure
* Chronic pulmonary disease
* Active infection not associated with Felty’s syndrome

Contraindications for Use of Gold Salts

* Severe liver or kidney disease
* Blood and marrow disorders

Contraindications for Use of Sulphasalazine

* Allergy to salicylates or sulfonamides

  #2

Thanks a lot Drpkaur. I was thinking of compiling that list. You made it easy for me.


___________________
Even if you are on the right track, you will get run over if you just sit there...KEEP RUNNING







You don't have permission to post.




Login or Register to post messages in this topic





















Contact | Leaders | Disclaimer | Privacy

Copyright @ Prep for USMLE. All rights reserved.